XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Deficit
Total Stockholders’ Equity
Noncontrolling Interest
Total
Balance at Dec. 31, 2022 $ 9 $ 529,466 $ (355,212) $ 174,263 $ 908 $ 175,171
Balance (in Shares) at Dec. 31, 2022 91,380 448          
Net income (loss) (25,933) (25,933) (119) (26,052)
Stock-based compensation 1,192 1,192 1,192
Issuance of stock under equity compensation plans
Issuance of stock under equity compensation plans (in Shares) 265            
Issuance of stock upon underwritten offering, net of costs $ 2 57,198 57,200 57,200
Issuance of stock upon underwritten offering, net of costs (in Shares) 13,400          
Impact of transactions affecting NCI (103) (103) 103
Balance at Mar. 31, 2023 $ 11 587,753 (381,145) 206,619 892 207,511
Balance (in Shares) at Mar. 31, 2023 105,045 448          
Balance at Dec. 31, 2022 $ 9 529,466 (355,212) 174,263 908 175,171
Balance (in Shares) at Dec. 31, 2022 91,380 448          
Net income (loss)             (66,706)
Balance at Jun. 30, 2023 $ 11   589,145 (421,632) 167,524 688 168,212
Balance (in Shares) at Jun. 30, 2023 105,323 428          
Balance at Mar. 31, 2023 $ 11 587,753 (381,145) 206,619 892 207,511
Balance (in Shares) at Mar. 31, 2023 105,045 448          
Net income (loss) (40,487) (40,487) (167) (40,654)
Stock-based compensation 1,661 1,661 1,661
Exchange of stock
Exchange of stock (in Shares) 20 (20)          
Proportional Representation Preferred Linked Stock redemption fee (105) (105) (105)
Additional costs associated with underwritten public stock offering (201) (201) (201)
Issuance of stock under equity compensation plans
Issuance of stock under equity compensation plans (in Shares) 258            
Impact of transactions affecting NCI 37 37 (37)
Balance at Jun. 30, 2023 $ 11   589,145 (421,632) 167,524 688 168,212
Balance (in Shares) at Jun. 30, 2023 105,323 428          
Balance at Dec. 31, 2023 $ 11 591,380 (475,969) 115,422 185 115,607
Balance (in Shares) at Dec. 31, 2023 105,507 205          
Net income (loss) (50,217) (50,217) (51) (50,268)
Stock-based compensation 492 492 492
Issuance of stock for Intellibed acquisition
Issuance of stock for Intellibed acquisition (in Shares) 1,500          
Issuance of stock under equity compensation plans (115) (115) (115)
Issuance of stock under equity compensation plans (in Shares) 473          
Impact of transactions affecting NCI (33) (33) 33
Balance at Mar. 31, 2024 $ 11 591,724 (526,186) 65,549 167 65,716
Balance (in Shares) at Mar. 31, 2024 107,480 205          
Balance at Dec. 31, 2023 $ 11 591,380 (475,969) 115,422 185 115,607
Balance (in Shares) at Dec. 31, 2023 105,507 205          
Net income (loss)             (50,277)
Balance at Jun. 30, 2024 $ 11 592,541 (526,159) 66,393 139 66,532
Balance (in Shares) at Jun. 30, 2024 107,503 205          
Balance at Mar. 31, 2024 $ 11 591,724 (526,186) 65,549 167 65,716
Balance (in Shares) at Mar. 31, 2024 107,480 205          
Net income (loss) 27 27 (36) (9)
Stock-based compensation 825 825 825
Issuance of stock under equity compensation plans
Issuance of stock under equity compensation plans (in Shares) 23            
Impact of transactions affecting NCI (8) (8) 8
Balance at Jun. 30, 2024 $ 11 $ 592,541 $ (526,159) $ 66,393 $ 139 $ 66,532
Balance (in Shares) at Jun. 30, 2024 107,503 205